Conformational isomers of a class II MHC-peptide complex in solution

Journal of Molecular Biology

Volumn 286, Issue 1, 1999, Pages 207-218

  Schmitt, Lutz ^a   Boniface, J Jay ^b   Davis, Mark M ^b   McConnell, Harden M ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

19F NMR; Major histocompatibility complex (MHC); Protein ligand interaction; Structural isomers of MHC peptide complexes

Indexed keywords

CYTOCHROME C; FLUORINE; ISOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PIGEON; PRIORITY JOURNAL; SOLUTION AND SOLUBILITY; T LYMPHOCYTE;

EID: 0033548189     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2463     Document Type: Article

References (41)

1. Beeson C., McConnell H. M. Kinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class II. Proc. Natl. Acad. Sci. USA. 91:1994;8842-8845.
2. Beeson C., Anderson T. G., McConnell H. M. Isomeric complexes of peptides with class II proteins of the major histocompatibility complex. J. Am. Chem. Soc. 118:1996;977-980.
3. Boniface J. J., Albritton N. L., Reay P. A., Kantor R. M., Stryer L., Davis M. M. pH affects the mechanism and the specificity of peptide binding to a class II major histocompatibility complex molecule. Biochemistry. 32:1993;11761-11768.
4. Boniface J. J., Lyons D. S., Wettstein D. A., Allbritton N. L., Davis M. M. Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced. J. Exp. Med. 183:1996;119-126.
5. Brown L. H., Jardetzky T. S., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364:1993;33-39.
6. Carping L. A., Han G. Y. The 9-fluorenylmethoxycarbonyl amino-protecting group. J. Org. Chem. 37:1972;3404-3409.
7. Dessen A., Lawrence M., Cupo S., Zaller D. M., Wiley D. C. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity. 7:1997;473-481.
8. Driscoll P. C., Altmann J. D., Boniface J. J., Sakaguchi K., Reay P. A., Omichinski J. G., Appella E., Davis M. M. Two-dimensional nuclear magnetic resonance analysis of a labeled peptide bound to class II major histocompatibility complex molecule. J. Mol. Biol. 232:1993;342-350.
9. Evavold B. D., Allen P. M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 252:1991;1308-1310.
10. Evavold B. D., Williams S. G., Hsu B. L., Buus S., Allen P. M. Complete dissection of the Hb (64-76) determinant using T helper 1, T helper 2 and T cell hybridomas. J. Immunol. 148:1992;347-353.
11. Fodor P. J., Price V. E., Greenstein J. P. Preparation of L - and D -alanine by enzymatic resolution of acetyl- DL -alanine. J. Biol. Chem. 178:1949;503-509.
12. Fremont D. H., Hendrickson W. A., Marrack P., Kappler J. Structure of an MHC class II molecules with covalently bound single peptides. Science. 272:1996;1001-1004.
13. Gerig J. T. Fluorine NMR of proteins. Prog. NMR Spectrosc. 26:1994;293-370.
14. Gosh P., Amaya M., Mellins E., Wiley D. C. The structure of an intermediate in class II maturation: CLIP bound to HLA-DR3. Nature. 378:1995;457-462.
15. Hardin C. C., Horrowitz J. Mobility of individual 5-fluorouridine residues in 5-fluorouracil-substituted Escherichia coli valine transfer RNA. J. Mol. Biol. 197:1987;555-569.
16. Hedrick S., Edelmann F. J. Paul W. E. Fundamental Immunology. 1993;Raven, New York.
17. Huang P., Dong A., Caughey W. S. Effects of dimethyl sulfoxide, glycerol, and ethylene glycol on secondary structures of cytochrome c and lysozyme as observed by infrared spectroscopy. J. Pharm. Sci. 84:1995;387-392.
18. 19F nuclear spin relaxation mechanism in proteins. J. Mol. Biol. 98:1975;121-153.
19. Jardetzki T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Chi Y.-I., Stauffacher C., Strominger J. L., Wiley D. C. Three-dimensional structure of human class II histocompatibility molecule complexed with superantigen. Nature. 368:1994;711-718.
20. Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggest a common, polyproline II-like conformation for bound peptides. Proc. Natl Acad. Sci. USA. 93:1996;734-738.
21. Johannson H., Denisov V., Halle B. Dimethyl sulfoxide binding to globular proteins: a nuclear magnetic dispersion study. Protein Sci. 6:1997;1756-1763.
22. 19F NMR. Nature. 271:1978;184-185.
23. halmethyltransferase-DNA interactions in solution. EMBO J. 17:1998;317-324.
24. Lee C., McConnell H. M. A general mode of invariant chain association with class II major histocompatibility complex proteins. Proc. Natl Acad. Sci. USA. 92:1995;8269-8273.
25. k. Proc. Natl Acad. Sci. USA. 91:1994;12463-12466.
26. kform and dissociation rapidly at neutral pH. J. Immunol. 1995;5216-5227.
27. Matsui K., Boniface J. J., Steffner P., Reay P. A., Davis M. M. Kinetics of T-cell receptor binding to peptide/I-Ek complexes correlation of the dissociation rate with T-cell responsiveness. Proc. Natl Acad. Sci. USA. 91:1994;12862-12866.
28. 19F nuclear magnetic resonance observations. J. Mol. Biol. 205:1989;149-164.
29. Millett F., Raftery M. A. An NMR method for characterizing conformation changes in proteins. Biochem. Biophys. Res. Commun. 47:1972;625-632.
30. 19F nuclear magnetic study. Biochemistry. 29:1990;3256-3262.
31. Rabinowitz J. D., Liang M. N., Tate K., Lee C., Beeson C., McConnell H. M. Specific T cell recognition of kinetic isomers in the binding of peptides to class II major histocompatibility complex. Proc. Natl Acad. Sci. USA. 94:1997;8702-8707.
32. Rabinowitz J. D., Vrljic M., Kasson P. M., Liang M. N., Busch R., Boniface J. J., Davis M. M., McConnell H. M. Formation of a highly peptide-receptive state of class II MHC. Immunity. 9:1998;699-709.
33. Reay P. A., Kantor R. M., Davis M. M. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152:1994;3946-3957.
34. Runnels H. A., Moore J. C., Jensen P. E. A structural transition in class II major histocompatibility complex proteins at mildly acidic pH. J. Exp. Med. 183:1996;127-136.
35. k. Nature. 338:1989;274-276.
36. Sadegh-Naseri S., Stern L. J., Wiley D. C., Germain R. N. MHC class II function preserved by low-affinity peptide interactions proceeding stable binding. Nature. 370:1994;647-650.
37. Schmitt L., Boniface J. J., Davis M. M., McConnell H. M. Kinetic isomers of a class II MHC-peptide complex. Biochemistry. 37:1998;17371-17380.
38. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L., Wiley D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 386:1994;215-221.
39. Sykes B. D., Hull W. E. Fluorine nuclear magnetic resonance studies of proteins. Methods Enzymol. 49:1978;270-295.
40. Viner N. J., Nelson C. A., Deck B., Unanue E. R. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J. Immunol. 156:1996;2365-2368.
41. Wettstein D., Boniface J. J., Reay P. A., Schild H., Davis M. M. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J. Exp. Med. 174:1991;219-228.